Zydus begins Phase IV EVIDENCES-XI Trial To Generate Real World Evidence Of Saroglitazar Mg In NAFLD Patients With Comorbidities
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52.
Source: freepressjournal.in
